$NVCR
NovoCure Ltd

2017 Q2 Form 10-Q Financial Statement

#000156459017020089 Filed on October 26, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $38.38M $17.92M
YoY Change 114.16% 173.87%
Cost Of Revenue $13.20M $9.800M
YoY Change 34.69% 104.17%
Gross Profit $25.22M $1.710M
YoY Change 1375.09% -4.63%
Gross Profit Margin 65.73% 9.54%
Selling, General & Admin $31.40M $27.60M
YoY Change 13.77% 70.01%
% of Gross Profit 124.48% 1614.04%
Research & Development $9.400M $11.30M
YoY Change -16.81% -11.72%
% of Gross Profit 37.27% 660.82%
Depreciation & Amortization $1.810M $1.410M
YoY Change 28.37% 138.98%
% of Gross Profit 7.18% 82.46%
Operating Expenses $40.70M $39.00M
YoY Change 4.36% 140.24%
Operating Profit -$15.53M -$37.24M
YoY Change -58.29% 36.87%
Interest Expense -$2.200M -$600.0K
YoY Change 266.67% -25.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$17.70M -$37.80M
YoY Change -53.17% 34.52%
Income Tax $3.500M $2.800M
% Of Pretax Income
Net Earnings -$21.17M -$40.61M
YoY Change -47.86% 38.34%
Net Earnings / Revenue -55.18% -226.64%
Basic Earnings Per Share
Diluted Earnings Per Share -$240.4K -$476.0K
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $184.4M $200.9M
YoY Change -8.21% 22.87%
Cash & Equivalents $80.19M $80.87M
Short-Term Investments $104.2M $120.0M
Other Short-Term Assets $1.500M $100.0K
YoY Change 1400.0% -95.24%
Inventory $25.10M $21.20M
Prepaid Expenses
Receivables $13.90M
Other Receivables $11.50M
Total Short-Term Assets $236.5M $234.7M
YoY Change 0.77% 29.74%
LONG-TERM ASSETS
Property, Plant & Equipment $18.70M $14.70M
YoY Change 27.21% 63.33%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.900M $1.076M
YoY Change 76.58% -62.9%
Total Long-Term Assets $20.50M $15.82M
YoY Change 29.57% 32.95%
TOTAL ASSETS
Total Short-Term Assets $236.5M $234.7M
Total Long-Term Assets $20.50M $15.82M
Total Assets $257.0M $250.5M
YoY Change 2.59% 29.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.20M $22.00M
YoY Change -40.0% 64.18%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $35.20M $34.62M
YoY Change 1.68% 55.24%
LONG-TERM LIABILITIES
Long-Term Debt $96.80M $23.29M
YoY Change 315.59% -4.93%
Other Long-Term Liabilities $7.600M $3.371M
YoY Change 125.45% 98.29%
Total Long-Term Liabilities $104.4M $29.26M
YoY Change 256.86% 11.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $35.20M $34.62M
Total Long-Term Liabilities $104.4M $29.26M
Total Liabilities $139.5M $63.87M
YoY Change 118.4% 31.7%
SHAREHOLDERS EQUITY
Retained Earnings -$464.1M
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $117.5M $186.6M
YoY Change
Total Liabilities & Shareholders Equity $257.0M $250.5M
YoY Change 2.59% 29.94%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$21.17M -$40.61M
YoY Change -47.86% 38.34%
Depreciation, Depletion And Amortization $1.810M $1.410M
YoY Change 28.37% 138.98%
Cash From Operating Activities -$5.875M -$29.39M
YoY Change -80.01% 26.74%
INVESTING ACTIVITIES
Capital Expenditures $376.0K $2.338M
YoY Change -83.92% -179.25%
Acquisitions
YoY Change
Other Investing Activities $640.0K -$10.00K
YoY Change -6500.0% -99.97%
Cash From Investing Activities -$587.0K -$6.630M
YoY Change -91.15% -82.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $781.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.067M 900.0K
YoY Change 129.67% -99.04%
NET CHANGE
Cash From Operating Activities -5.875M -29.39M
Cash From Investing Activities -587.0K -6.630M
Cash From Financing Activities 2.067M 900.0K
Net Change In Cash -4.395M -35.12M
YoY Change -87.49% -208.76%
FREE CASH FLOW
Cash From Operating Activities -$5.875M -$29.39M
Capital Expenditures $376.0K $2.338M
Free Cash Flow -$6.251M -$31.73M
YoY Change -80.3% 56.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000
CY2017Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-279000
CY2017Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11221000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
250820000
CY2016 nvcr Stock Issued During Period Value Exercise Of Options And Warrants
StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrants
993000
CY2016 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
616000
CY2016 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
698000
CY2016 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-378000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20760000
nvcr Stock Issued During Period Value Exercise Of Options And Warrants
StockIssuedDuringPeriodValueExerciseOfOptionsAndWarrants
3095000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
781000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
421000
CY2016 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-38000
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2053000
CY2017Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
72000
CY2016Q3 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
222000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21441000
CY2017Q3 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
592000
CY2016Q3 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-27000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
1861000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
-15000
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
180000
CY2016Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
72870000
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80190000
CY2016 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
698000
CY2017Q3 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
19000
CY2016Q3 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
17000
CY2017Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1732000
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3095000
CY2017Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
1713000
CY2016Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
34951000
CY2016Q3 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
72853000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3839000
CY2017Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
-2000
CY2016Q3 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
8000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
8000
CY2017Q3 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1914000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-17676000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
5117088
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
80871000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
119423000
CY2017Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2335000
CY2016Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
4624000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
7237000
CY2017Q3 us-gaap Interest Paid
InterestPaid
2561000
CY2016Q3 us-gaap Interest Paid
InterestPaid
1880000
us-gaap Interest Paid
InterestPaid
7603000
CY2017Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
104419000
CY2016Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
119825000
CY2017Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5936000
CY2016Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
5243000
CY2017Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10621000
CY2016Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
8292000
CY2017Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
8085000
CY2016Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12014000
nvcr Operating Lease Expiration Description
OperatingLeaseExpirationDescription
The facilities of the Company are leased under various operating lease agreements for periods ending no later than 2024.
CY2017Q3 us-gaap Deposits Assets
DepositsAssets
1051000
CY2016Q4 us-gaap Deposits Assets
DepositsAssets
807000
CY2017Q3 nvcr Operating Lease And Other Contractual Commitments
OperatingLeaseAndOtherContractualCommitments
1212000
CY2016Q4 nvcr Operating Lease And Other Contractual Commitments
OperatingLeaseAndOtherContractualCommitments
955000
CY2017Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1418711
CY2017Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.59
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1370810
nvcr Ordinary Shares Issued Upon Option Exercise
OrdinarySharesIssuedUponOptionExercise
1364645
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11377354
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
14812939
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
310693
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6119710
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
9.96
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.31
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.39
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.46
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
8.17
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
10.46
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8629000
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5626000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20760000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
16719000
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21441000
CY2017Q3 us-gaap Noncurrent Assets
NoncurrentAssets
18309000
CY2016Q4 us-gaap Noncurrent Assets
NoncurrentAssets
18620000

Files In Submission

Name View Source Status
0001564590-17-020089-index-headers.html Edgar Link pending
0001564590-17-020089-index.html Edgar Link pending
0001564590-17-020089.txt Edgar Link pending
0001564590-17-020089-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2017102519012943710432.jpg Edgar Link pending
nvcr-10q_20170930.htm Edgar Link pending
nvcr-20170930.xml Edgar Link completed
nvcr-20170930.xsd Edgar Link pending
nvcr-20170930_cal.xml Edgar Link unprocessable
nvcr-20170930_def.xml Edgar Link unprocessable
nvcr-20170930_lab.xml Edgar Link unprocessable
nvcr-20170930_pre.xml Edgar Link unprocessable
nvcr-ex311_6.htm Edgar Link pending
nvcr-ex312_9.htm Edgar Link pending
nvcr-ex321_8.htm Edgar Link pending
nvcr-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending